A randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients
Authors:
- Saeed HosseiniSHSaeed Hosseini
- Jeongmin LeeJLJeongmin Lee
- Ramon T. SepulvedaRSRamon T. Sepulveda
- Peter RohdewaldPRPeter Rohdewald
- Ronald R. WatsonRWRonald R. Watson
- 1 September 2001
- journal article
- Published by Elsevier in Nutrition Research
- Vol. 21 (9) , 1251-1260
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Pine bark extract reduces platelet aggregationIntegrative Medicine, 2000
- Endothelium-Dependent Vascular Effects of PycnogenolJournal of Cardiovascular Pharmacology, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US PopulationHypertension, 1995
- How Well Are the Cardiovascular Risk Profiles Modulated by Current Beta Blockers in Hypertension?Cardiology, 1993
- Alterations in heart sarcolemmal Ca2+-ATPase and Ca2+-binding activities due to oxygen free radicalsBasic Research in Cardiology, 1990
- Renal function in rats with angiotensin li-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockadeJournal Of Hypertension, 1990
- Free radical effects on membrane protein in myocardial ischemia/reperfusion injury†Journal of Molecular and Cellular Cardiology, 1987
- Differential sensitivity of canine cardiac sarcolemmal and microsomal enzymes to inhibition by free radical-induced lipid peroxidation.Circulation Research, 1984
- Thromboxane A2 in blood vessel walls and its physiological significance: Relevance to thrombosis and hypertensionProstaglandins and Medicine, 1980